In the months that followed the publication of the proposed rule and during the comment period, the FDA made available to the public over 200,000 pages of documents which were cited by the agency or considered in the promulgation of the rule.
During the comment period, the FDA had over 200,000 pages made available to the public, but had no impact on the final promulgation of the rule.